CN110198706A - 摄入的和吸收的分子的智能递送 - Google Patents

摄入的和吸收的分子的智能递送 Download PDF

Info

Publication number
CN110198706A
CN110198706A CN201780082689.9A CN201780082689A CN110198706A CN 110198706 A CN110198706 A CN 110198706A CN 201780082689 A CN201780082689 A CN 201780082689A CN 110198706 A CN110198706 A CN 110198706A
Authority
CN
China
Prior art keywords
composition
fatty acids
sfa
present
carotenoids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780082689.9A
Other languages
English (en)
Chinese (zh)
Inventor
伊万·M·佩蒂娅
马雷克·奥尔洛夫斯基
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immd Sp ZoO
Original Assignee
Immd Sp ZoO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL419363A external-priority patent/PL419363A1/pl
Priority claimed from GBGB1705491.7A external-priority patent/GB201705491D0/en
Application filed by Immd Sp ZoO filed Critical Immd Sp ZoO
Publication of CN110198706A publication Critical patent/CN110198706A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00—Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30—Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/36—Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds characterised by the fats used
    • A23G1/38—Cocoa butter substitutes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/065—Diphenyl-substituted acyclic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G2200/00—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents
    • A23G2200/08—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF containing organic compounds, e.g. synthetic flavouring agents containing cocoa fat if specifically mentioned or containing products of cocoa fat or containing other fats, e.g. fatty acid, fatty alcohol, their esters, lecithin, paraffins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN201780082689.9A 2016-11-04 2017-11-03 摄入的和吸收的分子的智能递送 Pending CN110198706A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
PLP.419363 2016-11-04
PL419363A PL419363A1 (pl) 2016-11-04 2016-11-04 Inteligentne dostarczanie przyjmowanych i wchłanianych cząsteczek
GB201618733 2016-11-07
GB1618733.8 2016-11-07
GBGB1705491.7A GB201705491D0 (en) 2017-04-05 2017-04-05 Intelligent delivery of ingested and absorbed molecules
GB1705491.7 2017-04-05
PCT/EP2017/078242 WO2018083271A1 (en) 2016-11-04 2017-11-03 Inteligent delivery of ingested and absorbed molecules

Publications (1)

Publication Number Publication Date
CN110198706A true CN110198706A (zh) 2019-09-03

Family

ID=60382179

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780082689.9A Pending CN110198706A (zh) 2016-11-04 2017-11-03 摄入的和吸收的分子的智能递送

Country Status (8)

Country Link
US (2) US11696920B2 (enExample)
EP (1) EP3534884A1 (enExample)
JP (1) JP2019534329A (enExample)
CN (1) CN110198706A (enExample)
BR (1) BR112019008739A2 (enExample)
CA (1) CA3042592A1 (enExample)
IL (1) IL266385A (enExample)
WO (1) WO2018083271A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115305207A (zh) * 2022-07-01 2022-11-08 厦门大学 一种全合成培养基、制备方法及其用于三孢布拉氏霉菌的培养方法

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12094109B2 (en) * 2018-10-19 2024-09-17 Takeda Pharmaceutical Company Limited Image scoring for intestinal pathology
MX2022001238A (es) * 2019-08-13 2022-07-13 Team Foods Colombia Sa Composicion lipidica que comprende antioxidantes y polifenoles naturales como alternativa no farmacologica para el tratamiento y la prevencion de nafld.

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134294A1 (en) * 2004-12-09 2006-06-22 Pro-Health, Inc. Product and method for oral administration of nutraceuticals
WO2009037562A2 (en) * 2007-09-19 2009-03-26 Ophthalmopharma Ag Nutritional supplement formulations and fortified foods comprising such supplements
WO2010074940A1 (en) * 2008-12-23 2010-07-01 Alcon Research, Ltd. Compositions and nutritional supplements for improving ocular health and reducing ocular inflammatory response
WO2010125516A1 (en) * 2009-04-29 2010-11-04 Graal Srl Compositions containing a mixture of lutein and zeaxanthine and coated with chocolate
WO2011107259A1 (en) * 2010-03-05 2011-09-09 Ophthalmopharma Ag Nutraceutical chocolate or compound chocolate product
AU2011218634A1 (en) * 2005-10-26 2011-09-15 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
WO2012131493A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions for the treatment of neurologic disorders
CN104080354A (zh) * 2011-12-02 2014-10-01 Ip科技有限公司 基于可可的食物制品
CN105828816A (zh) * 2013-11-12 2016-08-03 雅培公司 包含天然维生素e和多不饱和脂肪酸的营养组合物的用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05292885A (ja) 1992-04-22 1993-11-09 Asahi Denka Kogyo Kk チョコレート組成物
CN1516592A (zh) * 2001-06-18 2004-07-28 �����Ǽ���&������Դ���޹�˾ 用于预防和/或治疗心血管疾病、关节炎、皮肤癌、糖尿病、经前综合症和透皮转运的磷虾和/或海产提取物
MY135783A (en) * 2001-09-07 2008-06-30 Meiji Dairies Corp Nutritional composition for controlling blood sugar level
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
US20070116696A1 (en) * 2003-10-03 2007-05-24 Green Meadows Research, Llc Lotus and methyl donors
ES2241503B2 (es) * 2005-04-19 2008-07-01 Eduardo Sabio Rey Procedimiento para preparar formulaciones enriquecidas en licopeno libres de disolventes organicos, formulaciones obtenidas, composiciones que comprenden dichas formulaciones y uso de las mismas.
EP2374452B1 (en) 2008-12-05 2019-07-24 Ajinomoto Co., Inc. Nutrient composition
US20140205627A1 (en) * 2010-04-30 2014-07-24 U.S. Nutraceuticals, Llc D/B/A Valensa International Composition and method to improve blood lipid profiles and reduce low density lipoprotein (ldl) per-oxidation in humans using algae based oils and astaxanthin
CN101816330B (zh) * 2010-05-31 2012-04-18 澳优乳业（中国）有限公司 一种含β-胡萝卜素的婴幼儿奶粉及其制备方法
GB201101669D0 (en) 2011-01-31 2011-03-16 Ip Science Ltd Carotenoid particles and uses thereof
US20140170247A1 (en) * 2012-09-14 2014-06-19 Guardion Health Sciences, Llc Emulsion of Carotenoids and Ocular Antioxidants
FR2996136B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association d'au moins un acide gras polyinsature et d'au moins un carotenoide pour ameliorer la qualite des ongles.
US9629820B2 (en) * 2012-12-24 2017-04-25 Qualitas Health, Ltd. Eicosapentaenoic acid (EPA) formulations

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134294A1 (en) * 2004-12-09 2006-06-22 Pro-Health, Inc. Product and method for oral administration of nutraceuticals
AU2011218634A1 (en) * 2005-10-26 2011-09-15 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
WO2009037562A2 (en) * 2007-09-19 2009-03-26 Ophthalmopharma Ag Nutritional supplement formulations and fortified foods comprising such supplements
WO2010074940A1 (en) * 2008-12-23 2010-07-01 Alcon Research, Ltd. Compositions and nutritional supplements for improving ocular health and reducing ocular inflammatory response
WO2010125516A1 (en) * 2009-04-29 2010-11-04 Graal Srl Compositions containing a mixture of lutein and zeaxanthine and coated with chocolate
WO2011107259A1 (en) * 2010-03-05 2011-09-09 Ophthalmopharma Ag Nutraceutical chocolate or compound chocolate product
WO2012131493A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions for the treatment of neurologic disorders
CN104080354A (zh) * 2011-12-02 2014-10-01 Ip科技有限公司 基于可可的食物制品
CN105828816A (zh) * 2013-11-12 2016-08-03 雅培公司 包含天然维生素e和多不饱和脂肪酸的营养组合物的用途

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115305207A (zh) * 2022-07-01 2022-11-08 厦门大学 一种全合成培养基、制备方法及其用于三孢布拉氏霉菌的培养方法
CN115305207B (zh) * 2022-07-01 2024-04-12 厦门大学 一种全合成培养基、制备方法及其用于三孢布拉氏霉菌的培养方法

Also Published As

Publication number Publication date
US20200261482A1 (en) 2020-08-20
US20230310470A1 (en) 2023-10-05
JP2019534329A (ja) 2019-11-28
US11696920B2 (en) 2023-07-11
IL266385A (en) 2019-06-30
EP3534884A1 (en) 2019-09-11
WO2018083271A1 (en) 2018-05-11
CA3042592A1 (en) 2018-05-11
BR112019008739A2 (pt) 2019-07-09

Similar Documents

Publication Publication Date Title
JP7581151B2 (ja) マルチサプリメント組成物
US20230310470A1 (en) Intelligent delivery of ingested and absorbed molecules
AU2011260037B2 (en) Dietary formulations
Kapoor et al. Coenzyme Q10-a novel molecule
JP5337030B2 (ja) 皮膚および毛髪用の、リコピン異性体の安定で生物学的利用可能な組成物
US20110014279A1 (en) Bioactive complex compositions and methods of use thereof
US20080254135A1 (en) Resveratrol-containing compositions for general health and vitality
JPWO2008143182A1 (ja) 甘草ポリフェノールを含有する組成物
CA2593423A1 (en) Therapeutic uses of tomato extracts
RU2438358C2 (ru) Устойчивые и биологически доступные композиции изомеров каротиноидов для кожи и волос
CN107105695A (zh) 具有增强的抗氧化性的海洋卵磷脂制剂
EP1736149A2 (en) Astaxanthin-containing agent for lowering neutral fat concentration in blood
CA3109520C (en) Cannabinoids compositions with polyunsaturated fatty acid monoglycerides, methods and uses thereof
US9034399B2 (en) Dietary compositions for promoting brain health
Wang et al. Resveratrol and Spirulina: Nutraceuticals that Potentially Improve Cardiovascular Disease
WO2014184655A1 (en) Methods for using crustacean phospholipid-peptide-protein complexes
HK40013945A (en) Inteligent delivery of ingested and absorbed molecules
CA2585010A1 (en) Resveratrol-containing compositions for general health and vitality
CN101404996A (zh) 含有木脂素类化合物的组合物
Dhara et al. Oils and fats-largely unexplored source of nutraceuticals
Saini et al. Nutraceutical Potential of Lycopene and Tomatoes
WO2025146681A1 (en) Pro-nano-emulsions comprising omega 3 and use thereof
EP4014758A1 (en) Lipid composition comprising antioxidants and natural polyphenols as a non-pharmacological alternative for the treatment and prevention of non-alcoholic fatty liver disease (nafld)
IES85984Y1 (en) Dietary formulations
IE20110260U1 (en) Dietary formulations

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40013945

Country of ref document: HK

WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190903